When the transcriptional alterations of ATP6V1C2, SLC18A2, ADORA2, and CELF6 are considered together, it is speculated that seafood-derived Pls alleviate the pathology of AD mainly by modulating synaptic vesicle trafficking, promoting neurotransmitter transport, and synaptic transmission. Here, SLC18A2 is linked to Alzheimer disease.